Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Yaqrit logo — The Liver Disease Company

Yaqrit

The Liver Disease Company

Founded 2014 United Kingdom London, United Kingdom 13 employees Convertible Note Total: $15.70M Biotechnology, Health Care +3

General Information

Company Name Yaqrit
Founded Year 2014
Location United Kingdom London, United Kingdom +1
Employees 13
Industries Biotechnology, Health Care, Life Sciences +2
Funding Stage Convertible Note
Social

Get notified when Yaqrit moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Yaqrit

Yaqrit Limited, known as "The Liver Disease Company", is at the forefront of developing innovative treatments for liver disease, aiming to revolutionize patient care globally. Founded in 2014, this United Kingdom-based biotechnology startup is a spinout from University College London (UCL), one of the world’s top universities.

The company’s foundation is strongly rooted in over 20 years of extensive research led by Professor Rajiv Jalan and his team at the Royal Free Hospital campus. Yaqrit operates within key industries such as Biotechnology, Health Care, Life Sciences, Medical Devices, and Pharmaceutical, showcasing a diversified approach to tackling liver disease.

Its last financial injection was a Convertible Note investment on 03 September 2020 by Trend Investment Group. With its strategic focus on cutting-edge liver disease solutions and robust academic backing, Yaqrit presents a compelling investment opportunity within the life sciences sector.

Taxonomy: Liver Disease Treatments, Chronic Liver Disease, Medical Spinout, University Collaboration, Biomedical Research, Life Sciences, Professor Rajiv Jalan, Translational Medicine, Innovative Therapies, Healthcare Innovation, Treatment Development, Liver Cirrhosis Solutions, Advanced Biomedical Solutions

Services & Products

Research and development of treatments for advanced liver disease
Clinical trials for new liver disease therapies
Development of microbiome-based therapeutics

Target Customers

Patients with advanced liver disease Healthcare professionals Medical researchers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1 •••• •••• 03 Sep 2020
Private Equity Round •••••• 1 •••• •••• 09 Jul 2020
Angel Round •••••• - 01 Dec 2016
Grant •••••• 1 •••• •••• 01 Dec 2016
Angel Round •••••• 1
Investor
17 Dec 2015

View All 6 Funding Rounds

Yaqrit Alternatives & Competitors

View All Alternatives
Yaqrit vs
HepaTx Corporation
HepaTx Corporation United States

Off-the-shelf cell therapies for liver disease

Seed
3 employees
Biotechnology, Health and Wellness
Yaqrit vs
Morphocell Technologies
Morphocell Technologies Canada

Transforming the treatment of liver disease

30 employees
Biotechnology
Yaqrit vs
Hunterdon Gastroenterology Associates
Hunterdon Gastroenterology Associates

Comprehensive care for liver disease and GI conditions, including advanced treatments for hemorrhoid...

Health Care
View all alternatives

FAQ About Yaqrit

The Liver Disease Company
Yaqrit was founded in 2014.
Yaqrit is headquartered in London, United Kingdom.
Yaqrit operates in the following industries: Biotechnology, Health Care, Life Sciences, Medical Devices, Pharmaceutical.
Yaqrit has approximately 13 employees.
Yaqrit has completed 6 funding rounds, raising a total of $15.70M. The latest funding stage is Convertible Note.
Yaqrit offers: Research and development of treatments for advanced liver disease, Clinical trials for new liver disease therapies, Development of microbiome-based therapeutics.
Top alternatives and competitors to Yaqrit include HepaTx Corporation, Morphocell Technologies, Hunterdon Gastroenterology Associates, HepQuant, LLC, Genotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Yaqrit and HepaTx Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Yaqrit and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy